Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment.
Wipfler
P
P
Paracelsus Medical University, Christian-Doppler-Klinik, University Hospital of Neurology, Salzburg, Austria. p.wipfler@salk.at
Oppermann
K
K
Pilz
G
G
Afazel
S
S
Haschke-Becher
E
E
Harrer
A
A
Huemer
M
M
Kunz
A
A
Golaszewski
S
S
Staffen
W
W
Ladurner
G
G
Kraus
J
J